StonvexLoading…
StonvexStonvexStonvexCore line items from FTDR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $451.00M | $2.09B | $1.66B | $1.04B |
Operating Income | $51.00M | $338.00M | $336.00M | $194.00M |
Net Income | $41.00M | $255.00M | $253.00M | $148.00M |
EPS (Diluted) | $0.57 | $3.42 | $3.38 | $1.96 |
Total Assets | $2.16B | $2.14B | $2.23B | $2.17B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $603.00M | $566.00M | $563.00M | $562.00M |
Free Cash Flow OCF − CapEx | $113.00M | $390.00M | $295.00M | $237.00M |
Shares Outstanding | 70.53M | 70.96M | 72.43M | 73.11M |